Can cephalosporins be used in the treatment of poststreptococcal glomerulonephritis (PSGN)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Use of Cephalosporins in Post-Streptococcal Glomerulonephritis (PSGN)

Cephalosporins can be safely used in the treatment of post-streptococcal glomerulonephritis (PSGN) when antibiotics are indicated, as they are effective against streptococcal infections and do not worsen kidney outcomes. 1

Understanding PSGN and Antibiotic Therapy

PSGN is an immune complex-mediated disease occurring 1-3 weeks after streptococcal pharyngitis or impetigo, where streptococcal antigens trigger immune complex deposition in glomerular tissue, causing inflammation and kidney damage 1, 2.

  • Antibiotics are indicated in PSGN to eliminate any persistent streptococcal infection and decrease antigenic load, even if active infection is no longer present 1
  • The primary goal of antibiotic therapy is to eliminate nephritogenic strains of Streptococcus pyogenes from the patient and community 1, 3

Antibiotic Selection for PSGN

  • First-line treatment is penicillin (or erythromycin if penicillin-allergic) 1

  • Cephalosporins are an appropriate alternative when:

    • Penicillin allergy exists (non-anaphylactic type) 4
    • Treating outbreaks of PSGN in communities 3
    • Managing concurrent infections caused by beta-lactamase producing organisms 4
  • For severe infections or in areas with high prevalence of resistant organisms, third-generation cephalosporins are recommended as they have excellent coverage against streptococci 4

Evidence Supporting Cephalosporin Use

  • The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines support the use of cephalosporins for treating streptococcal infections 4
  • First-generation cephalosporins are particularly effective against streptococcal skin and soft tissue infections that may lead to PSGN 4
  • Systemic antimicrobials, including cephalosporins, are recommended during PSGN outbreaks to eliminate nephritogenic strains 1, 3

Clinical Considerations When Using Cephalosporins

  • Third-generation cephalosporins (like ceftriaxone) provide broad coverage and can be used for more severe infections 4
  • First-generation cephalosporins (like cephalexin) are appropriate for less severe cases and have excellent activity against streptococci 4
  • Cephalosporins should be administered for a complete course (typically 7-10 days) to ensure eradication of the organism 1

Important Caveats

  • Antibiotic therapy treats the underlying infection but does not alter the course of established PSGN, which is immune-mediated 1, 5

  • The mainstay of PSGN management remains supportive care, including:

    • Managing hypertension with diuretics and antihypertensive medications 1
    • Restricting dietary sodium intake 1
    • Monitoring for and treating fluid overload 1
    • Providing dialysis if necessary for severe cases 1
  • Kidney biopsy may be necessary in atypical presentations or when diagnosis is uncertain 1

Monitoring During Antibiotic Therapy

  • Regular assessment of kidney function, blood pressure, proteinuria, and hematuria should be performed 1
  • Monitor for adverse effects of diuretics including hyponatremia, hypokalemia, and volume depletion 1
  • Ensure complete eradication of streptococcal infection with appropriate antibiotic course 1, 3

In conclusion, cephalosporins are safe and effective antibiotics for treating streptococcal infections in patients with PSGN and represent a suitable alternative to penicillin when indicated.

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.